No data available.
Please log in to see this content.
You have no subscription access to this content.
No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
Apparent absence of a proton beam dose rate effect and possible differences in RBE between Bragg peak and plateau
1.K. Nihei, T. Ogino, S. Ishikura, and H. Nishimura, “High-dose proton beam therapy for stage I non-small-cell lung cancer,” Int. J. Radiat. Oncol., Biol., Phys. 65, 107–111 (2006).
2.M. Kawashima, J. Furuse, T. Nishio, M. Konishi, H. Ishii, T. Kinoshita, M. Nagase, K. Nihei, and T. Ogino, “Phase II study of radiotherapy employing proton beam for hepatocellular carcinoma,” J. Clin. Oncol. 23, 1839–1846 (2005).
3.H. Tsujii, T. Kamada, M. Baba, H. Tsuji, H. Kato, S. Kato, S. Yamada, S. Yasuda, T. Yanagi, H. Kato, R. Hara, N. Yamamoto, and J. Mizoe, “Clinical advantages of carbon-ion radiotherapy,” New J. Phys. 10, 075009–075024 (2008).
4.T. Miyamoto, M. Baba, M. Nakajima,. T. Yashiro, K. Kagei, N. Hirasawa, T. Sugawara, N. Yamamoto, M. Koto, H. Ezawa, K. Kadono, H. Tsujii, J. Mizoe, K. Yoshikawa, S. Kandatsu, and T. Fujisawa, “Carbon ion radiotherapy for stage I non-small cell lung cancer using a regimen of four fractions during 1 week,” J. Thorac. Oncol. 2(10), 916–926 (2007).
5.E. Pedroni et al., “The PSI Gantry 2: A second generation proton scanning gantry,” Med. Phys. 14, 25–34 (2004).
6.K. Ando, Y. Furusawa, M. Suzuki, K. Nojima, H. Majima, S. Koike, M. Aoki, W. Shimizu, Y. Futami, T. Ogino, S. Murayama, and H. Ikeda, “Relative biological effectiveness of the 235 MeV proton beams at the National Cancer Center Hospital East,” J. Radiat. Res. (Tokyo) 42, 79–89 (2001).
7.Y. Furusawa, M. Aoki, Y. Shino, R. Lee, G. Zhou, N. Takai, M. Monobe, T. Fukawa, Y. Miyato, and G. Kagiya, “Intercomparison of radiobiological RBE among Japanese proton therapy facilities,” in Proceedings of the World Congress on Medical Physics and Biomedical Engineering, Sydney, Australia, August 2003.
8.T. E. Schmid, G. Dollinger, A. Hauptner, V. Hable, C. Greubel, S. Auer, A. A. Friedl, M. Molls, and B. Röper, “No evidence for a different RBE between pulsed and continuous 20 MeV protons,” Radiat. Res. 172, 567–574 (2009).
9.T. E. Schmid, G. Dollinger, V. Hable, C. Greubel, O. Zlobinskaya, D. Michalski, M. Molls, and B. Röper, “Relative biological effectiveness of pulsed and continuous 20 MeV protons for micronucleus induction in 3D human reconstructed skin tissue,” Radiother. Oncol. 95, 66–72 (2010).
10.K. Shinohara, H. Nakano, N. Miyazaki, M. Tsgo, and R. Kodama, “Effects of single-pulse x-rays from laser-produced plasmas on mammalian cells,” J. Radiat. Res. (Tokyo) 45(4), 509–514 (2004).
11.H. B. Michaels, E. R. Epp, C. C. Ling, and E. C. Peterson, “Oxygen sensitization of CHO cells at ultrahigh dose rates: Prelude to oxygen diffusion studies,” Radiat. Res. 76, 510–521 (1978).
13.T. Nishio, “Present status and planning of facilities for proton and heavy ion cancer treatment in Japan. III. Present state of proton beam treatment facility in the National Cancer Center Hospital East,” J. At. Energy Soc. 41, 1134–1138 (1999).
14.T. Tachikawa, T. Sato, T. Ogino, and T. Nishio, “Proton beam therapy facilities of the National Cancer Center East Hospital,” Radiat. Indust. 84, 48–53 (1999).
15.T. Aso, A. Kimura, S. Tanaka, H. Yoshida, N. Kanematsu, T. Sasaki, and T. Akagi, “Verification of the dose distributions with Geant4 simulation for proton therapy,” IEEE Trans. Nucl. Sci. 52, 896–901 (2005).
16.J. F. Janni, “Calculations of energy loss, range, path length, straggling, multiple scattering, and the probability of inelastic nuclear collisions for 0.1- to 1000-MeV protons,” AFWL Technical Report No. 65-150 (Kirtland AFB, 1966).
17.D. Kirby, S. Green, H. Palmans, R. Hugtenburg, C. Wojnecki, and D. Parker, “LET dependence of GafChromic films and an ion chamber in low-energy proton dosimetry,” Phys. Med. Biol. 55, 417–433 (2010).
18.H. J. Baek, T. H. Kim, D. Shin, J. W. Kwak, D. W. Choo, S. B. Lee, Y. Furusawa, K. Ando, S. S. Kim, and K. H. Cho, “Radiobiological characterization of proton beam at the National Cancer Center in Korea,” J. Radiat. Res. (Tokyo) 49(5), 509–515 (2008).
19.Y. Shibamoto, M. Ito, C. Sugie, H. Ogino, and M. Hara, “Recovery from sublethal damage during intermittent exposures in cultured tumor cells: Implications for dose modification in radiosurgery and IMRT,” Int. J. Radiat. Oncol., Biol., Phys. 59, 1484–1490 (2004).
20.H. Ogino, Y. Shibamoto, C. Sugie, and M. Ito, “Biological effects of intermittent radiation in cultured tumor cells: Influence of fraction number and dose per fraction,” J. Radiat. Res. (Tokyo) 46, 401–406 (2005).
21.D. Bettega, M. Bombana, T. Pelucchi, A. Poli, L. Tallone Lombardi, and A. M. Fuhrman Conti, “Multinucleate cells and micronucleus formation in cultured human cells exposed to 12MeV protons and c-rays,” Int. J. Radiat. Biol. 37, 1–9 (1980).
22.D. Bettega, S. Dubini, A. M. Fuhrman Conti, T. Pelucchi, and L. Tallone Lombardi, “Chromosome aberrations induced by protons up to 31 MeV in cultured human cells,” Radiat. Environ. Biophys. 19, 91–100 (1981).
24.J. Gueulette, H. Blattmann, E. Pedroni, A. Coray, B. M. De Coster, P. Mahy, A. Wambersie, and G. Goitein, “Relative biologic effectiveness determination in mouse intestine for scanning proton beam at Paul Scherrer Institute, Switzerland. Influence of motion,” Int. J. Radiat. Oncol., Biol., Phys. 62(3), 838–845 (2005).
Article metrics loading...
Full text loading...
Most read this month